Drugs / serogroup B meningococcal vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00297817 Comparator | Feb 2006 → Apr 2007 | meningococcal infection | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | serogroup B meningococcal vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00297817 ↗ |
| Modality | Vaccine | “two serogroup B meningococcal vaccines” NCT00297817 ↗ |